Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Virology. 2016 Jan 14;489:282–291. doi: 10.1016/j.virol.2015.12.015

Fig. 6.

Fig. 6

The N-terminus of CypB is required for the enhancement of HIV infection. (A) Infection experiments were performed as described in legend of FIG 1 using indicated deletion mutants and a PPI inactive mutant. Results shown were normalized to cells transfected with empty vector control and are representative of a minimum of three replicate experiments. Asterisks indicated significant difference in infection compared to cells transfected with wild-type CypB (*= p<0.001 by two-tailed t-test). At the end of each experiment the expression of each mutant was verified by FLAG immunoblot of cell lysates (bottom panels). (B) Overall cell viability following expression of CypB and each mutant was monitored by MTT assay.